Abstract | BACKGROUND: OBJECTIVES: To establish an active animal model of PV to analyse the T-cell-regulated production of pathogenic antibodies in vivo. METHODS: Immunodeficient SCID mice were injected with peripheral blood lymphocytes (PBL) from an HLA-DRB1*0402/DQ8+ patient with PV or a DRB1*0402/DQ8+ healthy donor, with or without subsequent injections of human Dsg3 or preincubation of PBL with Dsg3. RESULTS: Human immunoglobulins (2.7-18.5 mg mL-1) were detected in all the mice after 8 weeks. Only one of 30 PBL-treated mice developed IgM against Dsg3 and showed intercellular IgM deposits in skin, nostrils and tongue. In contrast, in a previous study, 41% of SCID mice injected with PBL from patients with PV developed anti-Dsg3 antibodies in vivo. CONCLUSIONS: Our inability to reproduce these findings may be due to the transfer of slightly lower numbers of PBL (20 x 10(6) vs. 25-30 x 10(6)).
|
Authors | T Rädisch, R Riechers, M Hertl |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 146
Issue 2
Pg. 189-93
(Feb 2002)
ISSN: 0007-0963 [Print] England |
PMID | 11903226
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cadherins
- DSG3 protein, human
- Desmoglein 3
- HLA-DR Antigens
- HLA-DRB1 Chains
- HLA-DRB1*04:02 antigen
- Immunoglobulin M
|
Topics |
- Animals
- Autoimmunity
- Cadherins
(immunology)
- Desmoglein 3
- Disease Models, Animal
- Female
- HLA-DR Antigens
(immunology)
- HLA-DRB1 Chains
- Humans
- Immunoglobulin M
(biosynthesis)
- Lymphocyte Transfusion
- Mice
- Mice, SCID
- Models, Animal
- Pemphigus
(immunology)
|